TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06099262

Intervention type: BEHAVIORAL
Intervention: GenPMTO
Description: GenPMTO is a parenting programme which involves trained practitioners using active teaching approaches (such as group problem-solving, role-play, and video modelling) to support caregivers in using positive parenting strategies at home. The programme is designed to improve parenting practices, as well as a range of outcomes for young people, including improving academic performance, reducing school exclusions, and reducing offending and criminal behaviour. The version of the programme investigated in this project is delivered to groups of parents.

Intervention type: BEHAVIORAL
Intervention: GenPMTO
Description: GenPMTO is a parenting programme which involves trained practitioners using active teaching approaches (such as group problem-solving, role-play, and video modelling) to support caregivers in using positive parenting strategies at home. The programme is designed to improve parenting practices, as well as a range of outcomes for young people, including improving academic performance, reducing school exclusions, and reducing offending and criminal behaviour. The version of the programme investigated in this project is delivered to groups of parents.

Intervention type: BEHAVIORAL
Intervention: GenPMTO
Description: GenPMTO is a parenting programme which involves trained practitioners using active teaching approaches (such as group problem-solving, role-play, and video modelling) to support caregivers in using positive parenting strategies at home. The programme is designed to improve parenting practices, as well as a range of outcomes for young people, including improving academic performance, reducing school exclusions, and reducing offending and criminal behaviour. The version of the programme investigated in this project is delivered to groups of parents.

Intervention type: BEHAVIORAL
Intervention: GenPMTO
Description: GenPMTO is a parenting programme which involves trained practitioners using active teaching approaches (such as group problem-solving, role-play, and video modelling) to support caregivers in using positive parenting strategies at home. The programme is designed to improve parenting practices, as well as a range of outcomes for young people, including improving academic performance, reducing school exclusions, and reducing offending and criminal behaviour. The version of the programme investigated in this project is delivered to groups of parents.

Intervention type: BEHAVIORAL
Intervention: GenPMTO
Description: GenPMTO is a parenting programme which involves trained practitioners using active teaching approaches (such as group problem-solving, role-play, and video modelling) to support caregivers in using positive parenting strategies at home. The programme is designed to improve parenting practices, as well as a range of outcomes for young people, including improving academic performance, reducing school exclusions, and reducing offending and criminal behaviour. The version of the programme investigated in this project is delivered to groups of parents.
Study: NCT04978584

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Given PO
Study: NCT02341339

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic Surgery (Biopsies of fallopian tube lumen) using a laparoscopic brush/biopsy device
Study: NCT05627635

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo a PET scan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo a PET scan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo a PET scan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: X-Ray Imaging
Description: Undergo an x-ray

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: X-Ray Imaging
Description: Undergo an x-ray

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: X-Ray Imaging
Description: Undergo an x-ray
Study: NCT05467748

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tulmimetostat
Description: combination of oral tazemetostat and intravenous pembrolizumab treatment for patients with advanced non-small cell lung cancer
Study: NCT06141707

Intervention type: OTHER
Intervention: Arabic pediatric sleep questionnaire
Description: Pediatric Sleep Questionnaire (PSQ) developed and validated by chervil et al. (2000) is a 22 item questionnaire which had been shown to have a sensitivity of 81% and specificity of 87% for SRBD.These scales for childhood SRBDs, snoring, sleepiness, and behavior are valid and reliable instruments that can be used to identify SRBDs or associated symptom-constructs in clinical research when polysomnography is not feasible.

Intervention type: OTHER
Intervention: Arabic pediatric sleep questionnaire
Description: Pediatric Sleep Questionnaire (PSQ) developed and validated by chervil et al. (2000) is a 22 item questionnaire which had been shown to have a sensitivity of 81% and specificity of 87% for SRBD.These scales for childhood SRBDs, snoring, sleepiness, and behavior are valid and reliable instruments that can be used to identify SRBDs or associated symptom-constructs in clinical research when polysomnography is not feasible.

Intervention type: OTHER
Intervention: Arabic pediatric sleep questionnaire
Description: Pediatric Sleep Questionnaire (PSQ) developed and validated by chervil et al. (2000) is a 22 item questionnaire which had been shown to have a sensitivity of 81% and specificity of 87% for SRBD.These scales for childhood SRBDs, snoring, sleepiness, and behavior are valid and reliable instruments that can be used to identify SRBDs or associated symptom-constructs in clinical research when polysomnography is not feasible.
Study: NCT04958889

Intervention type: OTHER
Intervention: No intervention
Description: (observational study)

Intervention type: OTHER
Intervention: No intervention
Description: (observational study)

Intervention type: OTHER
Intervention: No intervention
Description: (observational study)

Intervention type: OTHER
Intervention: No intervention
Description: (observational study)
Study: NCT04932239

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: first aid education
Description: To teach commercial motorcyclists first aid for post-crash while waiting for medical team to reach the scene

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: first aid education
Description: To teach commercial motorcyclists first aid for post-crash while waiting for medical team to reach the scene
Study: NCT05771766

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Postural Drainge and aerobic training
Description: This will be a randomized controlled trial Patients will be divided into two groups randomly. Both groups will receive postural drainage as baseline treatment thrice a week for two weeks. The intervention group will undergo additional Aerobic Training thrice a week for two weeks as well along with postural drainage. Aerobic training will include 5-step stair-climbing and 10 step walk during each session.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Postural Drainage
Description: Postural Drainage
Study: NCT06472115

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supportive Parenting for Anxious Childhood Emotions (SPACE) for insistence on sameness (IS)
Description: This study will examine the potential effectiveness of a virtually delivered parent-mediated intervention for insistence on sameness behaviors in autism. This includes a 16 week protocol where caregivers meet weekly for one hour with a study therapist.
Study: NCT06188026

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC0194-0499
Description: Once a week for 5 weeks as an injection in dose of 30 mg. The injection will be given under the skin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ethinylestradiol/levonorgestrel
Description: Oral contraceptive is taken as tablet daily composed of 30 μg ethinylestradiol and 150 μg levonorgestrel.
Study: NCT06176742

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active Cycle Breathing Technique
Description: This study will be Randomized Clinical trial, Subject diagnosed with asthma meeting predetermined inclusion and exclusion criteria and will be divided into two groups. The baseline treatment for both groups would be diaphragmatic breathing exercises. While group A will be treated with ACBT. Each subject will receive 18 sessions with 3 treatments per week. Post treatment values will be recorded after the session and recorded values will be analyzed using SPSS 25.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bubble Positive Expiratory Pressure Device
Description: This study will be Randomized Clinical trial, Subject diagnosed with asthma meeting predetermined inclusion and exclusion criteria and will be divided into two groups. The baseline treatment for both groups would be diaphragmatic breathing exercises. While group B will be treated with bubble-PEP. Each subject will receive 18 sessions with 3 treatments per week. Post treatment values will be recorded after the session and recorded values will be analyzed using SPSS 25.
Study: NCT01078610

Intervention type: BIOLOGICAL
Intervention: adalimumab (Humira)
Description: 40 mg adalimumab (Humira) every other week.
Study: NCT05217940

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Diagnostic tests for anal cancer screening
Description: The initial screening interventions will include the collection of (1) anal cytology; (2) self-collected HPV testing specimens (by subjects); (3) a clinician collected HPV specimen. A digital rectal exam will also be done on all patients.
Study: NCT04928625

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A1904
Description: SHR-A1904
Study: NCT04978584

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Given IV

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tafasitamab
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vincristine
Description: Given IV
Study: NCT05995275

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1769
Description: Sterile liquid for injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1769
Description: Sterile liquid for injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1769
Description: Sterile liquid for injection

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9% sodium chloride injection (normal saline)
Study: NCT05689502

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Treatment
Description: Subjects will participate in 6 hours of therapy a day, 5 days a week, for 3 consecutive weeks. These sessions will include 2 hours of occupational therapy, 2 hours of physical therapy, and 2 hours of guided individual work. Some of these sessions will be in a group setting. The therapy sessions will be individualized to the subject's personal goals and will focus on improving the function of the arm most affected by the stroke. Sessions may include electrical stimulation of the muscles, if it is determined to be safe. At the end of each week, the therapists will recommend exercises for the subjects to continue to work on at home on the weekend.
Study: NCT06415552

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Mindfulness-Based Stress Reduction
Description: Eight iterations of the MBSR course will be delivered, over a total period of 24 months. Each iteration will take place over 8 weeks. Courses would consist of 8 weekly sessions, led by certified mindfulness instructors. Sessions will include core meditation practices, psychoeducation, and home practices.
Study: NCT05522777

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Drink one bottle of Yakult a day
Description: Yakult is a branded probiotic drink with 8x10\^9 CFU Lacticaseibacillus paracasei strain Shirota
Study: NCT05666193

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CBCT Imaging
Description: Subjects are scheduled for two imaging sessions on the Ethos system with the HyperSight CBCT. One session is on the same day as the CT simulation scan for treatment planning. The second session is on the same day as the delivery of ther 21st treatment fraction. If the subject is sent for a mid-treatment FBCT for re-planning, a third HyperSight CBCT imaging session will be scheduled on the same day as the mid-treatment FBCT.
Study: NCT05278975

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RSO-021
Description: A naturally-occurring, sulfur-rich, cyclic oligopeptide antibiotic of the thiopeptide class.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RSO-021
Description: A naturally-occurring, sulfur-rich, cyclic oligopeptide antibiotic of the thiopeptide class.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RSO-021
Description: A naturally-occurring, sulfur-rich, cyclic oligopeptide antibiotic of the thiopeptide class.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RSO-021
Description: A naturally-occurring, sulfur-rich, cyclic oligopeptide antibiotic of the thiopeptide class.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RSO-021
Description: A naturally-occurring, sulfur-rich, cyclic oligopeptide antibiotic of the thiopeptide class.
Study: NCT04219046

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naloxégol oxalate
Description: Oral administration once daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral tablet
Description: Oral administration once daily
Study: NCT05417477

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: use of an e-health application
Description: Use of the e-health application throughout the duration of the study combined with the usual management of the disease and 20 physiotherapy sessions.
Study: NCT05582655

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ONLINE
Description: The ONLINE intervention applies the JASPER (Joint Attention, Symbolic Play, Engagement, and Regulation: Kasari et al., 2021) social communication intervention for young children with autism. The JASPER approach has been tested in a caregiver-mediated format where caregivers are taught to use the JASPER strategies with their children during play and home routine (e.g., Kasari et al., 2010; Kasari et al., 2014). The JASPER intervention is being adapted in this study to include online web based materials.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ONLINE
Description: The ONLINE intervention applies the JASPER (Joint Attention, Symbolic Play, Engagement, and Regulation: Kasari et al., 2021) social communication intervention for young children with autism. The JASPER approach has been tested in a caregiver-mediated format where caregivers are taught to use the JASPER strategies with their children during play and home routine (e.g., Kasari et al., 2010; Kasari et al., 2014). The JASPER intervention is being adapted in this study to include online web based materials.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: COACH
Description: COACH includes live synchronous caregiver coaching in the JASPER intervention model. Coaching follows prior published JASPER caregiver coaching protocols (e.g., Shire, Shih, Barriault, \& Kasari, 2022). This implementation strategy has been tested in a pilot study when applied by community early intervention providers (Shire, Baker Worthman, \& Arbuckle, 2021).
Study: NCT05419635

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Asundexian (BAY2433334)
Description: Study intervention BAY2433334 will be administered as tablet taken orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Asundexian (BAY2433334)
Description: Study intervention BAY2433334 will be administered as tablet taken orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Asundexian (BAY2433334)
Description: Study intervention BAY2433334 will be administered as tablet taken orally.
Study: NCT04809532

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transverse abdominis plane (TAP) block
Description: Ultrasound guide bilateral TAP block at end of cesarean section

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacain
Description: 20ml 0.25% bupvicaine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tramadol
Description: intravenous tramadol
Study: NCT05370625

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Totum-854
Description: To compare Totum-854 with Placebo on blood pressure

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Five capsules per day to consume orally in two intakes
Study: NCT05148221

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Once each participant signs an informed consent form upon agreeing to participate in the study, they will be asked to complete a simple demographic questionnaire including year in program, work schedule, self-reported height and weight, age, and sex. They will also be interviewed by a faculty of university of Wisconsin-Eau Claire (UWEC) regarding their current and past exercise habits, exercise preferences, and perceived exercise barriers. Two questionnaires listed above (Occupational Fatigue Exhaustion Recovery (OFER 15) and Maslach Burnout Inventory (MBI)) will also be completed by each participant on Qualtrics online platform.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Actigraph and activPAL devices
Description: Actigraph and activPAL devices will be set up based on the demographic information and will be provided to each participant to wear for 7 consecutive days during all waking hours and sleep, except when bathing or swimming. If the first 7-day monitoring period was an overnight inpatient week, the second 7-day monitoring period will be scheduled during a non-overnight week. A day before the first day of the second monitoring period, a new set of Actigraph and activPAL devices will be delivered to each participant. Once the second monitoring period ends, devices will be retrieved from each participant, and data will be downloaded from devices.
Study: NCT05032300

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Focused shockwave
Description: Procedure: Focused shockwave therapy received shock wave therapy once a week: first locate, touch on the heel of the patient Tenderness points, take tenderness points as treatment points;Then ask the patient to take the lower limbs straight sitting or prone position, Target intensity will be within a range of 0.15-0.25 mJ/mm2 at maximum Hz, Total of 3000 pulses; rest for 20 minutes after the treatment

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home therapy
Description: Stretching and ice massage

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home therapy
Description: Stretching and ice massage
Study: NCT06158893

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salbutamol
Description: inhalation anaesthesia
Study: NCT05831592

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Muscle ultrasound
Description: Muscle ultrasound assessment (sensitivity, specificity) in undernutrition in patients
Study: NCT06158893

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Budesonide
Description: inhalation anaesthesia

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: saline
Study: NCT06305806

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivabradine
Description: Participants will receive ivabradine for 3 months (12 weeks) with a follow-up period for an additional 3 months (total study duration of 6 months).
Study: NCT06098937

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Kalifilcon Toric Lens
Description: Kalifilcon A Daily Disposable Toric for Ametropia
Study: NCT04961944

Intervention type: OTHER
Intervention: Disease assessment
Description: A comprehensive evaluation of the disease's extension, its impact on function, quality of life, and the search for phenotype/endotypes will be performed.~The association between endotypes and disease progression will be tested.
Study: NCT06098937

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Total1 for Astigmatism
Description: Total1 for Astigmatism

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Precision1 for Astigmatism
Description: Precision1 for Astigmatism

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MyDay Toric
Description: MyDay Toric
Study: NCT06411002

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DAXXIFY
Description: Intramuscular injection of daxibotulintoxinA-lanm
Study: NCT06222580

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspiration and Biopsy
Description: Undergo bone marrow aspiration and biopsy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gilteritinib
Description: Given PO
Study: NCT06222580

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Revumenib
Description: Given PO
Study: NCT05616481

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic Burch colposuspension
Description: The original Burch procedure will be performed

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Modefied Burch (TOT - like)
Description: more lateral fixation to avoid post-operative voiding dysfunction